FDA Drug Recalls

Recalls / Class II

Class IID-0126-2017

Product

Testosterone 200 mg/Anastrozole 9 mg Pellet, Compounded by: Wells Pharmacy Network

Affected lot / code info
BUD: 10/04/2016, Lot number 04072016@40 BUD: 12/03/2016, Lot number 06162016@2 BUD: 01/07/2017, Lot number CA07112016@4

Why it was recalled

Superpotent and Subpotent drugs

Recalling firm

Firm
Wells Pharmacy Network, LLC
Notification channel
Telephone
Type
Voluntary: Firm initiated
Address
450 US Hwy 51 Byp N, Dyersburg, Tennessee 38024-3655

Distribution

Quantity
690 pellets
Distribution pattern
U.S.

Timeline

Recall initiated
2016-09-19
FDA classified
2016-11-08
Posted by FDA
2016-11-16
Terminated
2017-03-29
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0126-2017. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls